Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
MondoA drives muscle lipid accumulation and insulin resistance
Byungyong Ahn, Shibiao Wan, Natasha Jaiswal, Rick B. Vega, Donald E. Ayer, Paul M. Titchenell, Xianlin Han, Kyoung Jae Won, Daniel P. Kelly
Byungyong Ahn, Shibiao Wan, Natasha Jaiswal, Rick B. Vega, Donald E. Ayer, Paul M. Titchenell, Xianlin Han, Kyoung Jae Won, Daniel P. Kelly
View: Text | PDF
Research Article Metabolism Muscle biology

MondoA drives muscle lipid accumulation and insulin resistance

  • Text
  • PDF
Abstract

Obesity-related insulin resistance is associated with intramyocellular lipid accumulation in skeletal muscle. We hypothesized that contrary to current dogma, this linkage is related to an upstream mechanism that coordinately regulates both processes. We demonstrate that the muscle-enriched transcription factor MondoA is glucose/fructose responsive in human skeletal myotubes and directs the transcription of genes in cellular metabolic pathways involved in diversion of energy substrate from a catabolic fate into nutrient storage pathways, including fatty acid desaturation and elongation, triacylglyceride (TAG) biosynthesis, glycogen storage, and hexosamine biosynthesis. MondoA also reduces myocyte glucose uptake by suppressing insulin signaling. Mice with muscle-specific MondoA deficiency were partially protected from insulin resistance and muscle TAG accumulation in the context of diet-induced obesity. These results identify MondoA as a nutrient-regulated transcription factor that under normal physiological conditions serves a dynamic checkpoint function to prevent excess energy substrate flux into muscle catabolic pathways when myocyte nutrient balance is positive. However, in conditions of chronic caloric excess, this mechanism becomes persistently activated, leading to progressive myocyte lipid storage and insulin resistance.

Authors

Byungyong Ahn, Shibiao Wan, Natasha Jaiswal, Rick B. Vega, Donald E. Ayer, Paul M. Titchenell, Xianlin Han, Kyoung Jae Won, Daniel P. Kelly

×

Figure 5

MondoA deficiency ameliorates insulin signaling and glucose uptake.

Options: View larger image (or click on image) Download as PowerPoint
MondoA deficiency ameliorates insulin signaling and glucose uptake.
(A) ...
(A) Western blot analysis of phosphorylated AKT (p-AKT S473) and total AKT in response to insulin (1.0 U/kg for 10 minutes) in gastrocnemius muscle lysates. Quantification of p-AKT/total AKT ratio was determined by Image Studio Lite software (n = 4–6 mice per group). Representative Western blots are shown at the bottom. The data represent mean ± SEM. *P < 0.05 vs. WT/CD, #P < 0.05 vs. WT/CD with insulin, and †P < 0.05 vs. WT/HFD by 1-way ANOVA with Tukey’s multiple-comparisons post hoc test. (B) Basal and insulin-stimulated 2DG uptake measured in isolated (ex vivo) soleus muscles with or without insulin (15 mU/mL for 15 minutes, n = 7–10 mice per group). The data represent mean ± SEM. *P < 0.05 vs. WT/CD, #P < 0.05 vs. WT/CD with insulin, and †P < 0.05 vs. WT/HFD by 1-way ANOVA with Tukey’s multiple-comparisons post hoc test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts